EcoDrugPlus

Delta-Type Opioid Receptor

Ensembl ID : ENSAMXG00000018191
Gene Symbol: LOC103032206
3 Cross references
200 Possible Orthologues:

Delta-Type Opioid Receptor

Ensembl ID : ENSAMXG00000040361
Gene Symbol: LOC103040064
3 Cross references
215 Possible Orthologues:

Delta-Type Opioid Receptor-Like

Ensembl ID : ENSAMXG00000039980
Gene Symbol: LOC103039256
2 Cross references
197 Possible Orthologues:

Diacylglycerol O-Acyltransferase 1

Ensembl ID : ENSAMXG00000037012
Gene Symbol: LOC103031398
3 Cross references
188 Possible Orthologues:

Diacylglycerol O-Acyltransferase 1a

Ensembl ID : ENSAMXG00000033776
Gene Symbol: DGAT1A
1 Cross references
192 Possible Orthologues:

Dihydroorotate Dehydrogenase (Quinone)

Ensembl ID : ENSAMXG00000036900
Gene Symbol: DHODH
3 Cross references
173 Possible Orthologues:

Dihydropyrimidine Dehydrogenase

Ensembl ID : ENSAMXG00000000135
Gene Symbol: DPYD
3 Cross references
214 Possible Orthologues:

Discoidin Domain Receptor Tyrosine Kinase 2

Ensembl ID : ENSAMXG00000011496
Gene Symbol: DDR2
3 Cross references
205 Possible Orthologues:

Dopamine Receptor D1

Ensembl ID : ENSAMXG00000025106
Gene Symbol: DRD1
2 Cross references
188 Possible Orthologues:

Dopamine Receptor D1b

Ensembl ID : ENSAMXG00000024960
Gene Symbol: DRD1B
1 Cross references
200 Possible Orthologues:

Dopamine Receptor D3

Ensembl ID : ENSAMXG00000014808
Gene Symbol: DRD3
3 Cross references
202 Possible Orthologues:

Dopamine Receptor D4

Ensembl ID : ENSAMXG00000034740
Gene Symbol: DRD4
3 Cross references
176 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).